Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
Abstract
Background: Advanced glycation end products (AGEs) and the receptor for AGE (RAGE) play an important role in the development of diabetic vascular complications. This study aimed at investigating the relationship between the soluble form of RAGE (sRAGE), endogenous secretory RAGE (esRAGE), and pentosidine in childhood diabetes. Methods: The study included 18 children with type 1 diabetes mellitus (T1DM), 10 with type 2 DM (T2DM), and 22 age-matched, non-diabetic children (control). Results: Serum sRAGE levels in the T1DM (2557.7 pg/mL) were significantly higher than both T2DM (1956.4 pg/mL) and control (1658.5 pg/mL). The circulating levels of esRAGE in T1DM and T2DM children were similar, but significantly higher than those of control. Serum pentosidine levels in the T1DM group were positively correlated with serum sRAGE and esRAGE levels, but not with anthropometric or biochemical measurements. The duration of diabetes and esRAGE levels were independent predictors of the circulating sRAGE levels. Conclusions: Unlike adults, children with diabetes exhibit high circulating esRAGE levels, and both sRAGE and esRAGE levels are correlated with pentosidine levels. These results suggest that circulating sRAGE and esRAGE in children may be surrogate markers for progressive glucose toxicity in pediatric patients with childhood-onset diabetes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The three RAGE forms bind various ligands with similar affinities, including AGEs and amyloid β peptide.
“The three RAGE forms bind various ligands with similar affinities, including multiple advanced glycation end-products (AGEs) and amyloid β peptide31–37.”
From Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice (2019) · cites this paper as [36]
Cites
1 retracted
Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Toth, C. C., Rong, L., Yang, C., Martinez, J., Song, F., Ramji, N., Brussee, V., Liu, W., Durand, J., Nguyen, M. D., et al. (2007) · Diabetes · doi:10.2337/db07-0339 · Cited by 187 · see citing works
RetractedAdvanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · see citing works
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · see citing works
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,542 · see citing works
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082 · see citing works
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945 · see citing works
Saito, M., & Marumo, K. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 914 · see citing works
YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716 · see citing works
Self-citationAdvanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & Caterina, R. D. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544 · see citing works
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475 · see citing works
Self-citationWautier, J., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 434 · see citing works
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407 · see citing works
Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190660.32863.cd · Cited by 311 · see citing works
Self-citationAdvanced Glycation End Products-driven Angiogenesis in Vitro
Yamagishi, S., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., O'OKA, H., Satozawa, N., Kawakami, T., Nomura, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8723 · Cited by 274 · see citing works
Self-citationYamamoto, M., Yamaguchi, T., Yamauchi, M., Yano, S., & Sugimoto, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1270 · Cited by 262 · see citing works
Miyata, T., Taneda, S., Kawai, R., Ueda, Y., Horiuchi, S., Hara, M., Maeda, K., & Monnier, V. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2353 · Cited by 191 · see citing works
Soluble forms of RAGE in internal medicine
Vazzana, N., Santilli, F., Cuccurullo, C., & Davı̀, G. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0300-1 · Cited by 166 · see citing works
Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 159 · see citing works
Yamagishi, S.-I., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.007 · Cited by 148 · see citing works
Soluble RAGE in type 2 diabetes: Association with oxidative stress
Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucciarelli, L. G., Michetti, N., Clissa, C., Ciabattoni, G., Consoli, A., & Davı̀, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.015 · Cited by 145 · see citing works
Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., Sato, A., & Imaizumi, T. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.690 · Cited by 143 · see citing works
Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., & Imaizumi, T. (2007) · Molecular Medicine · doi:10.2119/2006-00090.nakamura · Cited by 134 · see citing works
Choi, K. M., Han, K. A., Ahn, H. J., Hwang, S. Y., Hong, H. C., Choi, H. Y., Yang, S. J., Yoo, H. J., Baik, S. H., Choi, D. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1951 · Cited by 103 · see citing works
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
Kerkeni, M., Saïdi, A., Bouzidi, H., Letaief, A., Yahia, S. B., & Hammami, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112460253 · Cited by 93 · see citing works
Challier, M., Jacqueminet, S., Benabdesselam, O., Grimaldi, A., & Beaudeux, J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051961 · Cited by 84 · see citing works
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82 · see citing works
Galler, A., Müller, G., Schinzel, R., Kratzsch, J., Kieß, W., & Münch, G. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2609 · Cited by 80 · see citing works
Yamagishi, S., Matsui, T., & Nakamura, K. (2007) · Current Drug Targets · doi:10.2174/138945007782151298 · Cited by 73 · see citing works
Development of an ELISA for esRAGE and its application to type 1 diabetic patients
Sakurai, S., Yamamoto, Y., Tamei, H., Matsuki, H., Obata, K., Hui, L., Miura, J., Osawa, M., Uchigata, Y., Iwamoto, Y., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.12.013 · Cited by 68 · see citing works
Self-citationKatakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T., Sakamoto, K., Yasuda, T., & Yamasaki, Y. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.031 · Cited by 61 · see citing works
Pino, A. D., Urbano, F., Zagami, R. M., Filippello, A., Mauro, S. D., Piro, S., Purrello, F., & Rabuazzo, A. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4069 · Cited by 50 · see citing works
Yamagishi, S., Adachi, H., Takeuchi, M., Enomoto, M., Furuki, K., Matsui, T., Nakamura, K., & Imaizumi, T. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-991176 · Cited by 36 · see citing works
Accacha, S. D., Rosenfeld, W., Jacobson, A., Michel, L., Schnurr, F. J., Shelov, S. P., Ten, S., Boucher‐Berry, C., Carey, D. E., Speiser, P., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000354831 · Cited by 32 · see citing works
Chiavaroli, V., D’Adamo, E., Giannini, C., de Giorgis, T., Marco, S. D., Chiarelli, F., & Mohn, A. (2012) · Diabetes Care · doi:10.2337/dc11-2302 · Cited by 26 · see citing works
Miura, J., Uchigata, Y., Yamamoto, Y., Takeuchi, M., Sakurai, S., Watanabe, T., Yonekura, H., Yamagishi, S., Makita, Z., Satô, A., et al. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00281-7 · Cited by 25 · see citing works
Self-citationDettoraki, A., Gil, A. P. R., & Spiliotis, B. E. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.10.895 · Cited by 25 · see citing works
Ng, Z. X., Chua, K. H., Iqbal, T., & Kuppusamy, U. R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047480 · Cited by 22 · see citing works
Salonen, K. M., Ryhänen, S. J., Forbes, J. M., Borg, D. J., Härkönen, T., Ilonen, J., Simell, O., Veijola, R., Groop, P., & Knip, M. (2015) · Diabetes Care · doi:10.2337/dc14-1186 · Cited by 16 · see citing works
Yamamoto, Y., & Yamamoto, H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00125.x · Cited by 12 · see citing works
Self-citationΚουτρουμάνη, Ν., Partsalaki, I., Lamari, F. N., Dettoraki, A., Gil, A. P. R., Karvela, A., Kostopoulou, E., & Spiliotis, B. E. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0183 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice
Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0325-6 · Cited by 171 · see citing works
Self-citationMacLean, M., Derk, J., Ruiz, H. H., Juranek, J. K., Ramasamy, R., & Schmidt, A. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.012 · Cited by 69 · see citing works
Steenbeke, M., Bruyne, S. D., Buyzere, M. D., Lapauw, B., Speeckaert, R., Petrović, M., Delanghe, J., & Speeckaert, M. M. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1791045 · Cited by 41 · see citing works
Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease
Lao, K., Zhang, R., Luan, J., Zhang, Y., & Gou, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200851 · Cited by 25 · see citing works
The association between Type 1 diabetes mellitus and periodontal diseases
Sun, K., Chen, S.-C., Lin, C., Hsu, J.-T., Chen, I.-A., Wu, I., Palanisamy, K., Shen, T., & Li, C. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.10.012 · Cited by 22 · see citing works
Metabolic syndrome and atherogenic indices in school children: A worrying panorama in Brazil
Barbalho, S. M., Oshiiwa, M., Fontana, L. C. S., Finalli, E. F. R., Filho, M. E. P., & Spada, A. P. M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.024 · Cited by 21 · see citing works
Glycation and Glucose Variability in Subjects with Type 1 Diabetes
Klimontov, V. V., Мухтаровна, Б. Д., & Semenova, J. F. (2024) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750824600080
Jia, M., Mei, J., Guan, Y., Wang, Z., & Ai, H. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00207
- Authors
- Saito, R., Araki, S., Yamamoto, Y., & Kusuhara, K.
- Affiliations
- University of Occupational and Environmental Health Japan (JP)
- Corresponding author
- Araki, Shunsuke
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-01-01
- Volume
- 30
- Issue
- 1
- Pages
- 63-69
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2563062922
- Cited by
- 8
- References
- 41
- Citations by year
- 2026: 1 · 2024: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (26461535)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- advanced glycation end products, receptor for advanced glycation end products, soluble RAGE, pentosidine, type 1 diabetes, type 2 diabetes, pediatric diabetes, diabetic vascular complications, glucotoxicity, biomarkers, diabetes duration
- MeSH terms
- Receptor for Advanced Glycation End Products, Adolescent, Adult, Child, Child, Preschool, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Prognosis, Biomarkers, Glycation End Products, Advanced, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
